Skip to main content

STAAR SURGICAL CO

For the period ended Dec 29, 2023. Filed Feb 27, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 27, 2024

STAA$23.87-2.8%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated Statements of Income

(In thousands, except per share amounts)

202320222021
Net sales$322,415$284,391$230,472
Cost of sales69,76461,00851,835
Gross profit252,651223,383178,637
Selling, general and administrative expenses:
General and administrative72,31954,74244,142
Selling and marketing107,83488,85667,294
Research and development44,40135,98333,862
Total selling, general and administrative expenses224,554179,581145,298
Operating income28,09743,80233,339
Other income (expense), net:
Interest income (expense), net6,9862,448(38)
Loss on foreign currency transactions(1,909)(1,707)(2,964)
Royalty income748041,015
Other income (loss), net448205(48)
Total other income (expenses), net5,5991,750(2,035)
Income before income taxes33,69645,55231,304
Provision for income taxes12,3495,8873,793
Net income$21,347$39,665$27,511
Net income per share:
Basic$0.44$0.83$0.58
Diluted$0.43$0.80$0.56
Weighted average shares outstanding:
Basic48,52347,98747,210
Diluted49,42749,38049,456
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.